Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)
- PMID: 15536144
- DOI: 10.1182/blood-2004-09-3548
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)
Abstract
On the basis of recent clinical and experimental data, natural killer (NK) cells appear to play a crucial role in eradication of acute myeloid leukemias. In the present study, by exploiting our current knowledge on NK receptors and their ligands on target cells, we investigated the interactions between NK and leukemic cells. We show that the size of the NK cell subset expressing the killer immunoglobulin-like receptor (KIR) not engaged by the HLA-class I alleles of the patient parallels the degree of NK cytotoxicity against leukemic cells. A sharp down-regulation of HLA-class I molecules has been detected in various leukemias and it was more frequent in myeloid than in lymphoblastic leukemias. Analysis of the ligands for triggering NK receptors revealed the consistent expression of Poliovirus receptor (PVR) and Nectin-2 in myeloid leukemias. In contrast, major histocompatibility complex class I-related chain molecules A/B (MICA/B) and UL1b-binding protein (ULBPs) were either absent or weakly expressed. Accordingly, NK-mediated lysis of these leukemias was dependent on DNAM-1 but not NKG2D. The major role of NKp46 and NKp30 was also confirmed. The expression of PVR and/or Nectin-2 was less frequent in lymphoblastic leukemias. In most leukemias, both CD48 and NTBA were down-regulated. The correlation found between marker expression and susceptibility to lysis may reveal useful information for NK-based immunotherapy.
Similar articles
-
Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction.Blood. 2006 Mar 1;107(5):2030-6. doi: 10.1182/blood-2005-07-2696. Epub 2005 Nov 22. Blood. 2006. PMID: 16304049
-
Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias.Blood. 2005 May 1;105(9):3615-22. doi: 10.1182/blood-2004-07-2585. Epub 2005 Jan 18. Blood. 2005. PMID: 15657183
-
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.Cancer Res. 2007 Sep 15;67(18):8444-9. doi: 10.1158/0008-5472.CAN-06-4230. Cancer Res. 2007. PMID: 17875681
-
Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells.Mol Immunol. 2002 Feb;38(9):637-60. doi: 10.1016/s0161-5890(01)00107-9. Mol Immunol. 2002. PMID: 11858820 Review.
-
Unravelling natural killer cell function: triggering and inhibitory human NK receptors.EMBO J. 2004 Jan 28;23(2):255-9. doi: 10.1038/sj.emboj.7600019. Epub 2003 Dec 18. EMBO J. 2004. PMID: 14685277 Free PMC article. Review.
Cited by
-
Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia.Front Oncol. 2013 Apr 29;3:99. doi: 10.3389/fonc.2013.00099. eCollection 2013. Front Oncol. 2013. PMID: 23641363 Free PMC article.
-
NK Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations.Transplant Cell Ther. 2021 Jan;27(1):21-35. doi: 10.1016/j.bbmt.2020.09.030. Epub 2020 Sep 29. Transplant Cell Ther. 2021. PMID: 33007496 Free PMC article. Review.
-
Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells.Front Immunol. 2013 Feb 1;4:15. doi: 10.3389/fimmu.2013.00015. eCollection 2013. Front Immunol. 2013. PMID: 23378843 Free PMC article.
-
Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.J Infect Dis. 2012 May 1;205(9):1351-62. doi: 10.1093/infdis/jis210. Epub 2012 Mar 29. J Infect Dis. 2012. PMID: 22457290 Free PMC article.
-
Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.J Virol. 2007 Sep;81(18):9707-17. doi: 10.1128/JVI.00887-07. Epub 2007 Jul 3. J Virol. 2007. PMID: 17609265 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous